Correlation Between Salesforce and Seoulin Bioscience

Can any of the company-specific risk be diversified away by investing in both Salesforce and Seoulin Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Seoulin Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Seoulin Bioscience CoLtd, you can compare the effects of market volatilities on Salesforce and Seoulin Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Seoulin Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Seoulin Bioscience.

Diversification Opportunities for Salesforce and Seoulin Bioscience

0.29

Correlation Coefficient

Salesforce  Seoulin Bioscience

Modest diversification

The 3 months correlation between Salesforce and Seoulin is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Seoulin Bioscience CoLtd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seoulin Bioscience CoLtd and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Seoulin Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seoulin Bioscience CoLtd has no effect on the direction of Salesforce i.e., Salesforce and Seoulin Bioscience go up and down completely randomly.

Pair Corralation between Salesforce and Seoulin Bioscience

Considering the 90-day investment horizon Salesforce is expected to under-perform the Seoulin Bioscience. In addition to that, Salesforce is 1.09 times more volatile than Seoulin Bioscience CoLtd. It trades about -0.14 of its total potential returns per unit of risk. Seoulin Bioscience CoLtd is currently generating about -0.05 per unit of volatility. If you would invest  696,490  in Seoulin Bioscience CoLtd on December 25, 2024 and sell it today you would lose (35,490) from holding Seoulin Bioscience CoLtd or give up 5.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	93.33%
Values	Daily Returns

Salesforce  vs.  Seoulin Bioscience CoLtd

Salesforce

Risk-Adjusted Performance

Very Weak

Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Seoulin Bioscience CoLtd

Risk-Adjusted Performance

Very Weak

Over the last 90 days Seoulin Bioscience CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Seoulin Bioscience is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Salesforce and Seoulin Bioscience

The main advantage of trading using opposite Salesforce and Seoulin Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Seoulin Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seoulin Bioscience will offset losses from the drop in Seoulin Bioscience's long position.

The idea behind Salesforce and Seoulin Bioscience CoLtd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.